⌘+K

Pulse Explore Communities Researchers Journals

Browser extensionInstagram

Home Communities Explore

April 10, 2024AIDSOpen Access

The effect of weight gain and metabolic dysfunction-associated steatotic liver disease on liver fibrosis progression and regression in people with HIV

Giovanni Guaraldi Jovana Milić Stefano Renzetti Federico Motta Felice Cinque Jenny Bischoff Andrea Desilani Jacopo Conti Filippo Medioli Martina del Monte Dana Kablawi Wesal Elgretli Stefano Calza Cristina Mussini Juergen Rockstroh Giada Sebastiani

View Full Paper

Ask AI

Bookmark

Share

Ask about this paper

Answers are grounded in this paper and cite their sources.

Ask your own question…

Abstract

People with HIV (PWH) have high risk of liver fibrosis. We investigated the effect of weight gain and metabolic dysfunction-associated steatotic liver disease (MASLD) on liver fibrosis dynamics.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Guaraldi et al. (2024) studied this question.

synapsesocial.com/papers/68e6f97db6db6435876742a1 https://doi.org/10.1097/qad.0000000000003903

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 10 related papers. Consider them for comparative context:

1Metabolic dysfunction-associated steatotic liver disease in people with HIV is associated with lower BMI and more liver fibrosis compared to the uninfected population2024 · 1 citations
2Weight Gain Is Associated with Short-Term FIB-4 Increase and Concurrent Metabolic Change in People with HIV and Metabolic Dysfunction-Associated Steatotic Liver DiseaseCohort Study · 2026
3Metabolic Dysfunction-Associated Steatotic Liver Disease in People Living with HIV: A Scoping ReviewReview · 2026 · 1 citations
4Evaluation of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in a Cohort of Older People Living with HIV/AIDSCohort Study · 2026
5Diabetes and risk of significant fibrosis in adults with HIV and metabolic dysfunction-associated steatotic liver disease: a prospective cohort studyCohort Study · 2026
6Liver metabolic health and the components of metabolic syndrome in people living with HIV – do they differ from those in a ‘healthy’ population?2025
7MASLD in people with HIV exhibits higher fibrosis stage despite lower disease activity than in matched controls2024 · 18 citations
8PREVALENCE AND SEVERITY OF STEATOTIC LIVER DISEASE IN WOMEN WITH AND WITHOUT HIVOriginal Research · 2026 · 1 citations
9Impact of doxycycline postexposure prophylaxis on sexually transmitted infections within a statewide community healthcare systemAIDS · 2026
10Health, workforce, and cost trade-offs of HIV programme prioritization strategies in MalawiAIDS · 2026

More from McGill University

More from McGill University Health Centre

More from University of Brescia

More from University of Modena and Reggio Emilia

More from GTx (United States)

More from University Hospital Bonn